Results from a randomized, double‐blind, placebo‐controlled, crossover, multimodal‐MRI pilot study of gabapentin for co‐occurring bipolar and cannabis use disorders-Reference-Cited by-同舟云学术

Results from a randomized, double‐blind, placebo‐controlled, crossover, multimodal‐MRI pilot study of gabapentin for co‐occurring bipolar and cannabis use disorders

Published:2021-08-14 Issue:1 Volume:27 Page:
ISSN:1355-6215
Container-title:Addiction Biology
language:en
Short-container-title:Addiction Biology

Author:

Prisciandaro James J.¹^ORCID,Mellick William¹,Squeglia Lindsay M.¹,Hix Sara¹,Arnold Lauren¹,Tolliver Bryan K.¹

Affiliation:

1. Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences Medical University of South Carolina Charleston South Carolina USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/adb.13085

Reference90 articles.

1. The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression

2. US Epidemiology of Cannabis Use and Associated Problems

3. Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis

4. Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates

5. Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Brexit council: winners and losers after the UK’s withdrawal from the EU;Journal of European Integration;2024-07-30

2. Emerging pharmacotherapy for the treatment of cannabis use disorder;Expert Opinion on Pharmacotherapy;2024-04-12

3. Catalyst-free decarboxylative cross-coupling of N-hydroxyphthalimide esters with tert-butyl 2-(trifluoromethyl)acrylate and its application;Organic & Biomolecular Chemistry;2024

4. Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management;Current Neuropharmacology;2023-04

5. N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial;Neuropsychopharmacology;2023-03-06